D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
KKR & Co
KKR
$91.3B
| $7.21M | 0.01% |
+147,618
| New | +$6.61M |
|
1477
Antero Resources
AR
$10.5B
| $7.21M | 0.01% |
706,774
-79,697
| -10% | -$675K |
|
1478
Methanex
MEOH
$4.19B
| $7.2M | 0.01% |
+195,041
| New | +$7.62M |
|
1479
CALL
Virgin Galactic
SPCE
$325M
| $7.2M | 0.01% |
+11,750
| New | +$8.85M |
|
1480
Progressive
PGR
$125B
| $7.19M | 0.01% |
75,183
-56
| -0.1% | -$5.09K |
|
1481
Accel Entertainment
ACEL
$1.01B
| $7.18M | 0.01% |
657,426
-5,510
| -0.8% | -$59K |
|
|
EXEEW
1482
DELISTED
Expand Energy Corp Class A Warrants
EXEEW
| $7.18M | 0.01% |
+372,820
| New | +$8.32M |
|
|
CS
1483
DELISTED
Credit Suisse Group
CS
| $7.18M | 0.01% |
677,432
-73,983
| -10% | -$1M |
|
1484
State Street SPDR S&P Retail ETF
XRT
$448M
| $7.18M | 0.01% |
+80,449
| New | +$6.51M |
|
1485
Northern Oil and Gas
NOG
$2.21B
| $7.16M | 0.01% |
593,057
+366,676
| +162% | +$4.4M |
|
1486
T-Mobile US
TMUS
$190B
| $7.16M | 0.01% |
57,181
+1,087
| +2% | +$137K |
|
1487
Sunstone Hotel Investors
SHO
$2.2B
| $7.16M | 0.01% |
574,581
-272,200
| -32% | -$3.25M |
|
1488
Pacific Biosciences
PACB
$422M
| $7.15M | 0.01% |
+214,545
| New | +$7.51M |
|
|
HR
1489
DELISTED
Healthcare Realty Trust Incorporated
HR
| $7.12M | 0.01% |
234,912
-242,864
| -51% | -$7.31M |
|
|
MSDAU
1490
DELISTED
MSD Acquisition Corp. Unit
MSDAU
| $7.11M | 0.01% |
+700,000
| New | +$7.02M |
|
1491
Wave Life Sciences
WVE
$1.14B
| $7.08M | 0.01% |
1,262,109
-237,150
| -16% | -$2.28M |
|
1492
PUT
Dell
DELL
$276B
| $7.05M | 0.01% |
157,840
-98,650
| -38% | -$4.04M |
|
1493
Bank of N.T. Butterfield & Son
NTB
$2.4B
| $7.05M | 0.01% |
184,498
+22,000
| +14% | +$776K |
|
1494
CVR Energy
CVI
$3.43B
| $7.04M | 0.01% |
366,885
+63,811
| +21% | +$1.3M |
|
1495
ICU Medical
ICUI
$4.04B
| $7.03M | 0.01% |
34,234
+10,563
| +45% | +$2.23M |
|
1496
Ralph Lauren
RL
$22.6B
| $7.03M | 0.01% |
+57,072
| New | +$6.51M |
|
|
MIMO
1497
DELISTED
Airspan Networks Holdings Inc
MIMO
| $7.03M | 0.01% |
702,812
+212,812
| +43% | +$2.18M |
|
|
AUS.U
1498
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
| $7.03M | 0.01% |
+700,000
| New | +$7.11M |
|
1499
Alaska Air
ALK
$5.3B
| $7.01M | 0.01% |
101,358
-196,586
| -66% | -$11.8M |
|
1500
CGI
GIB
$14.5B
| $7.01M | 0.01% |
84,100
+52,200
| +164% | +$4.13M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.